Samir J. Patel

Spectrum of sodium hypochlorite toxicity in man—also a concern for nephrologists

H. Kadikoy, B. Workeneh, A. Abdellatif, 2011, NDT plus.

Conversion from tacrolimus‐mycophenolate mofetil to tacrolimus‐mTOR immunosuppression after kidney‐pancreas transplantation reduces the incidence of both BK and CMV viremia

A. Gaber, E. Graviss, L. Gaber, 2018, Clinical transplantation.

Efficacy and Safety of Once-Daily LCP-Tacrolimus Versus Twice-Daily Immediate-Release Tacrolimus in Adult Hispanic Stable Kidney Transplant Recipients: Sub-Group Analysis from a Phase 3 Trial

S. Akkina, G. Guerra, S. Bunnapradist, 2021, Annals of transplantation.

Barriers to Preemptive Renal Transplantation: A Single Center Questionnaire Study

A. Gaber, E. Graviss, L. Teeter, 2015, Transplantation.

Ciprofloxacin for BK viremia prophylaxis in kidney transplant recipients: Results of a prospective, double‐blind, randomized, placebo‐controlled trial

A. Gaber, E. Graviss, D. Nguyen, 2019, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

Risk Factors and Consequences of Delayed Graft Function in Deceased Donor Renal Transplant Patients Receiving Antithymocyte Globulin Induction

A. Gaber, L. Gaber, M. Egidi, 2008, Transplantation.

The role of mTOR inhibition in renal transplant immune suppression

A. Gaber, L. Gaber, A. Abdellatif, 2011 .

Considerations in sirolimus use in the early and late post-transplant periods

A. Gaber, L. Gaber, R. Knight, 2009, Expert opinion on drug safety.

Donor-specific HLA-DQ antibodies may contribute to poor graft outcome after renal transplantation.

W. Suki, A. Gaber, L. Gaber, 2012, Kidney international.

Using genetic and clinical factors to predict tacrolimus dose in renal transplant recipients.

Stephen T. C. Wong, Xiaobo Zhou, A. Gaber, 2010, Pharmacogenomics.

Growth hormone use and abuse

Vanya D. Wagler, Samir J. Patel, H. Lemar, 2013 .

Effect of Immunosuppression for First Kidney or Kidney/Pancreas Transplant on Sensitization at the Time of Second Transplant

A. Gaber, Jiaqiong Xu, R. Knight, 2011, Transplantation.

Efficacy and cost‐effectiveness of voriconazole prophylaxis for prevention of invasive aspergillosis in high‐risk liver transplant recipients

A. Gaber, X. Li, R. Ghobrial, 2016, Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.